Differing effects of breast cancer 1, early onset (BRCA1) and ataxia‐telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation

References

• ABBOTT, D. W., THOMPSON, M. K, ROBINSON-BENION, C., TOMLINSON, G., JENSEN, R. A. and HOLT, J. T., 1999, BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. Journal of Biological Chemistry, 274, 18808–18812.
   Google Scholar
• BAUMANN, P., BENSON, F. E. and WEST, S. C., 1996, Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell, 87, 757–766.
   PubMed Web of Science ®Google Scholar
• BUNDEY, S., 1994, Clinical and genetic features of ataxia-telangiectasia. International Journal of Radiation Biology, 66 (Suppl.), S23–29.
   Google Scholar
• CANTOR, S. B., BELL, D. W., GANESAN, S., KAss, E. M., DRAPKIN, R., GROSSMAN, S., WAHRER, D. C., SGROI, D. C., LANE, W. S., HABER, D. A. and LIVINGSTON, D. M., 2001, BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell, 105, 149–160.
   PubMed Web of Science ®Google Scholar
• CHAPMAN, M. S. and VERMA, I. M., 1996, Transcriptional activation by BRCA1 [Letter; Comment]. Nature, 382, 678–679.
   PubMedGoogle Scholar
• CHEN, Y., FARMER, A. A., CHEN, C.-F., JONES, D. C., CHEN, P.-L. and LEE, W.-H., 1996, BRCA1 is a 220 kDa nuclear phosphoprotein that is expressed and phophorylated in a cell-cycle dependent manner. Cancer Research, 56, 3168–3172.
   Google Scholar
• CORTEZ, D., WANG, Y., QIN, J. and EITYDGE, S. J., 1999, Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks [see comments]. Science, 286, 1162–1166.
   PubMed Web of Science ®Google Scholar
• CUNLIFFE, P. N., MANN, J. R., CAMERON, A. H. and ROBERTS, K. D., 1975, Racliosensitivity in ataxia-telangiectasia. British Journal of Radiology, 48, 374–376.
   PubMed Web of Science ®Google Scholar
• DE TOLEDO, S. M., AZZAM, E. I., DAHLBERG, W. K., GOODING, T. B. and LrrrLE, J. B., 2000, ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation. Oncogene, 19, 6185–6193.
   PubMedGoogle Scholar
• FALCK, J., MAILAND, N., SYLJUASEN, R. G., BARTEK, J. and LUKAS, J., 2001, The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature, 410, 842–847.
   PubMed Web of Science ®Google Scholar
• FITZGERALD, M. G., BEAN, J. M., HEGDE, S. R., UNSAL, H., MACDONALD, D. J., HARKIN, D. P., FINKELSTEIN, D. M., ISSELBACHER, K. J. and HABER, D. A., 1997, Heterozygous ATM mutations do not contribute to early onset of breast cancer [see comments]. Nature Genetics, 15, 307–310.
   PubMed Web of Science ®Google Scholar
• FORAY, N., MAROT, D., RANDRIANARISON, V., VENEZIA, N. D., PICARD, D., PERRICAUDET, M., FAVAUDON, V. and JEGGo, P., 2002, Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation. Molecular and Cellular Biology, 22, 4020–4032.
   PubMed Web of Science ®Google Scholar
• FORAY, N., RANDRIANARISON, V., MAROT, D., PERRICAUDET, M., LENOIR, G. and FEUNTEUN, J., 1999, Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene, 18, 7334–7342.
   PubMed Web of Science ®Google Scholar
• GARCIA-HIGUERA, I., TANIGUCHI, S., GANESAN, S., MEYN, M. S., TIMMERS, C., HEJNA, J., GROMPE, M. and D'ANDREA, A. M., 2001, Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Molecular Cell, 7, 249–262.
   Google Scholar
• GATEI, M., YOUNG, D., CEROSALETPI, K. M., DESAI-MEHTA, A., SPRING, K., Kozwv, S., LAVIN, M. F., GATTI, R. A., CONCANNON, P. and KHAsTsTA, K., 2000, ATM-dependent phosphorylation of Nibrin in response to radiation exposure. Nature Genetics, 25, 115–119.
   Google Scholar
• GEOFFREY-PEREZ, B., JANIN, N., OSSIAN, K., LAUGE, A., STOPPA-LYONNET, D. and ANDRIEU, N., 2002, Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors. International Journal of Cancer, 99, 619–623.
   PubMedGoogle Scholar
• GOWEN, L. C., AVRUTSKAYA, A. V., LATOUR, A. M., KOLLER, B. H. and LEADON, S. A., 1998, BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science, 281, 1009–1012.
   PubMed Web of Science ®Google Scholar
• HAAF, T., GOLUB, E. I., REDDY, G., RADDING, C. M. and WARD, D. C., 1995, Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proceedings of the National Academy of Sciences, USA, 92, 2298–2302.
   PubMed Web of Science ®Google Scholar
• HARNDEN, D. G., 1994, The nature of ataxia-telangiectasia: Problems and perspectives. International Journal of Radiation Biology, 66 (Suppl.), S13–19.
   Google Scholar
• HAupT, Y., MAYA, R., KAZAZ, A. and OREN, M., 1997, Mdm2 promotes the rapid degradation of p53. Nature, 387, 296–299.
   PubMed Web of Science ®Google Scholar
• HECHT, F. and HEcur, B. K., 1990, Cancer in ataxia-telangiectasia patients. Cancer Genetics and Cytogenetics, 46, 9–19.
   PubMedGoogle Scholar
• HIRAO, A., KONG, Y. Y., MATSUOKA, S., WAKEHAM, A., RULAND, J., YOSHIDA, H., Liu, D., EITYDGE, S. J. and MAK, T. W., 2000, DNA damage-induced activation of p53 by the checkpoint kinase chk2 [see comments]. Science, 287, 1824–1827.
   Google Scholar
• HONDA, R., TANAKA, H. and YASUDA, H., 1997, Oncoprotein Moim2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters, 420, 25–27.
   PubMed Web of Science ®Google Scholar
• KASTAN, M. B., AHAN, Q, EL-DEWY, W. S., CARRIER, F., JACKS, T., WALSH, W. V., PLUNKETT, B. S., VOGELSTEIN, B. and FORNACE, A. J., 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangie ctasia. Cell, 71, 587–597.
   Google Scholar
• KHOSRAVI, R., MAYA, R., GOTTLIEB, T., OREN, M., SHILOH, Y. and SHKEDY, D., 1999, Rapid ATM-dependent phosphorylation of Moim2 precedes p53 accumulation in response to DNA damage. Proceedings of the National Academy of Sciences, USA, 96, 14973–14977.
   PubMed Web of Science ®Google Scholar
• KUEBITZ, S. J.5 PLUNKETT, B. S., WALSH, W. V. and KASTAN, M., 1992, Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences, USA, 89, 7491–7495.
   Google Scholar
• LARSON, J. S., TONKINSON, J. L. and LAI, M. T., 1997, A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. Cancer Research, 57, 3351–3355.
   PubMed Web of Science ®Google Scholar
• LAWN, M. F., CONCANNON, P. and GATTI, R. A., 1999, Eighth international workshop on ataxia-telangiectasia (ATW8). Cancer Research, 59, 3845–3849.
   PubMedGoogle Scholar
• "FY, J. S., COLLINS, K. M., BROWN, A. L., TjF, C. H. and CHUNG, J. H., 2000, Hcdsl-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature, 404, 201–204.
   Google Scholar
• Li, C.-Y., NAGASAWA, H., DAHLBERG, W. K. and LITTLE, J. B., 1995, Diminished capacity for p53 in mediating radiation-induced G1 arrest in established human tumor cell lines. Oncogene, 11, 1885–1892.
   Google Scholar
• Li, S., TING, N. S., ZHENG, L., CHEN, P. L., Zw, Y., SHILO, Y., LEE, E. Y. and LEE, W.-H., 2000, Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature, 406, 210–215.
   Google Scholar
• Lai, D. S., KIM, S. T., Xu, B., MASER, R. S., LIN, J., PETRINI, J. H. and KASTAN, M. B., 2000, ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature, 404, 613–617.
   PubMedGoogle Scholar
• LrrrrE, J. B., 1969, Repair of sub-lethal and potentially lethal radiation damage in plateau phase cultures of human cells. Nature, 224, 804–806.
   PubMedGoogle Scholar
• LrrrrE, J. B. and NAGASAWA, H., 1985, Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiation Research, 101, 81–93.
   PubMedGoogle Scholar
• MEvx, M. S., 1993, High spontaneous intrachromosomal recombination rates in ataxia-telangiectasia. Science, 260, 1327–1330.
   PubMedGoogle Scholar
• MOMAND, J., ZAMBETTI, G. P., OLSON, D. C., GEORGE, D. and LEVINE, A. J., 1992, The mclm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237–1245.
   PubMed Web of Science ®Google Scholar
• MOYNAHAN, M. E., Cum, J. W., KOLLER, B. H. and JAsix, M., 1999, BRCA1 controls homology-directed DNA repair. Molecular Cell, 4, 511–518.
   PubMed Web of Science ®Google Scholar
• NAGASAWA, H., LATP, S. A., LALANDE, M. E. and LITTLE, J. B., 1985, Effects of x-irradiation on cell-cycle progression, induction of chromosomal aberrations and cell killing in ataxia telangiectasia (AT) fibroblasts. Mutation Research, 148, 71–82.
   PubMed Web of Science ®Google Scholar
• NAGASAWA, H. and LITTLE, J. B., 1981, Induction of chromosome aberrations and sister chromatid exchanges by x rays in density-inhibited cultures of mouse 10T1/2 cells. Radiation Research, 87, 538–551.
   PubMed Web of Science ®Google Scholar
• NAGASAWA, H. and LITTLE," B., 1983, Comparison of kinetics of x-ray-induced cell killing in normal, ataxia telangiectasia and hereditary retinoblastoma fibroblasts. Mutation Research, 109, 297–308.
   Google Scholar
• NICHOLS, K. E., LEVTPZ, S., SHANNON, K. E., WAHRER, D. C., BRIJ, D. W., CHANG, G., HEDGE, S., NEUBERG, D., SHAFMAN, T., TARBELL, N. J., MAUCH, P., IsmoKA, C., HABER, D. A. and DILLER, L., 1999, Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. Journal of Clinical Oncology, 17, 1259–1266.
   PubMed Web of Science ®Google Scholar
• Oucm, T., MONTEIRO, A. N., AUGUST, A., AARONSON, S. A. and HANAFUSA, H., 1998, BRCA1 regulates p53-dependent gene expression. Proceedings of the National Academy of Sciences, USA, 95, 2302–2306.
   PubMedGoogle Scholar
• PAINTER, R. B. and YOUNG, B. R., 1980, Radiosensitivity in ataxia-telangiectasia: a new explanation. Proceedings of the National Academy of Sciences, USA, 77, 7315–7317.
   PubMed Web of Science ®Google Scholar
• PICKSLEY, S. M., VorrEsEx, B., SPARKS, A. and LANE, D. P., 1994, Immunochemical analysis of the interaction of p53 with MDM2-fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene, 9, 2523–2529.
   PubMed Web of Science ®Google Scholar
• PIPPARD, E. C., HALL, A. J., BARKER, D. J. and BRIDGES, B. A., 1988, Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Research, 48, 2929-2932.
   Google Scholar
• PRITCHARD, J., SANDLAND, M. R., BREATNACH, F. B., PE\TooTr, J. R., Cox, R. and HUSBAND, P., 1982, The effects of radiation therapy for Hodgkin's disease in a child with ataxia telangiectasia: A clinical, biological and pathologic study. Cancer, 50, 877–886.
   Google Scholar
• SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., Zw, Y., ZIV, VANAGAITE, L., TAGLE, D. A., SMITH, S., UZIEL, T. and SFEZ, S., et al. 1995, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749–1753.
   Google Scholar
• Scum-, S. P., BENDIX, R., CHEN, P., CLARK, R., DoRK, T. and LAVIN, M. F., 2002, Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proceedings of the National Academy of Sciences, USA, 99, 925–930.
   Google Scholar
• SCULLY, R., GANESAN, S., VLASAKOVA, K., CHEN, J., SOCOLOVSKY, M. and LIVINGSTON, D. M., 1999, Genetic analysis of BRCA1 function in a defined tumor cell line. Molecular Cell, 4, 1093–1099.
   PubMed Web of Science ®Google Scholar
• SCULLY, R., ANDERSON, S. F., CHAO, D. M., WET, W., YE, L., YOUNG, R. A., LIVINGSTON, D. M. and PARVIN, J. D., 1997a, BRCA1 is a component of the RNA polymerase II holoenzyme. Proceedings of the National Academy of Sciences, USA, 94, 5605–5610.
   PubMed Web of Science ®Google Scholar
• SCULLY, R., CHEN, J.5 OCHS, R. L., KEEGAN, K., HOEKSTRA, M., FEUNTEUN, J. and LIVINGSTON, D. M., 1997b, Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90, 425–435.
   Google Scholar
• SCULLY, R., CHEN, J., PLUG, A., XrAo, Y., WEAVER, D., FEUNTEUN, J., ASHLEY, T. and LIVINGSTON, D. M., 1997c, Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88, 265–275.
   PubMed Web of Science ®Google Scholar
• SHAEmAN, T. D., LEvrrz, S., NIXON, A. J., GIBANS, L. A., Nrcuors, K. E., BELL, D. W., ISHIOKA, C., ISSELBACHER, K. J., GELMAN, R., GARBER, J., Halms," R. and HABER, D. A., 2000, Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes and Cancer, 27, 124–129.
   Google Scholar
• SHEN, S.-X., WEAVER, Z., XU, X., LI, C., WEINSTEIN, M., CHEN, L., GU, X.-Y., RIED, T. and DENG, C.-X., 1998, A targeted disruption of the murine Brcal gene causes y-irradiation hypersensitivity and genetic instability. Oncogene, 17, 3115–3124.
   PubMed Web of Science ®Google Scholar
• SOMASUNDARAM, K. ZHANG, H., ZENG, Y. X., HOUVRAS, Y., PENG, Y., Wu, G. S., hour, J. D., WEBER, B. L. and Er-DEnty, W. S., 1997, Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/Cipl. Nature, 389, 187–190.
   Google Scholar
• SOMMER, S. S., BUZIN, C. H., JUNG, M., ZHENG, J., Liu, Q, JEONG, S. J., MOULDS, J., NGUYEN, V. Q, FENG, J., BENNETT', W. P. and DkrrscHrro, A., 2002, Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls. Cancer Genetics and Cytogenetics, 134, 25–32.
   Google Scholar
• SwiEr, M., 2001, Public health burden of cancer in ataxia-telangiectasia heterozygotes. Journal of the National Cancer Institute, 93, 84–85.
   PubMedGoogle Scholar
• TAYLOR, A. M., HARNDEN, D. G., ARLETT, C. F., HARCOURT, S. A" LEHMANN, A. R., STEVENS, S. and BRIDGES, B. A.5 1975, Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature, 258, 427–429.
   Google Scholar
• TERAOKA, S. N., MALONE, K. E., Doonv, D. R., SUTER, N. M., OSTRANDER, E. A., DALING, J. R. and CONCANNON, P., 2001, Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer, 92, 479–487.
   Google Scholar
• THACKER, J., 1994, Cellular racliosensitivity in ataxia-telangiectasia. International Journal of Radiation Biology, 66, S87—S96.
   Google Scholar
• TOMLINSON, G. E., CHEN, T. T., STASTNY, V. A., VIRIVIANI, A. K., SPILLMAN, M. A., TONK, V., BLUM," L., SCHNEIDER, N. R., WISTUBA li, SHAY, J. W., MINNA, J. D. and GAZDAR, A. F., 1998, Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Research, 58, 3237–3242.
   Google Scholar
• VAUGHN, J. P., DAVIS, P. L., JARBOE, M. D., HUPER, G., EVANS, A. C., WISEMAN, R. W., BERCHUCK, A., IGLEHART, J. D., FUTREAL, P. A. and MARKS, J. R., 1996, BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth and Differentiation, 7, 711–715.
   PubMedGoogle Scholar
• WANG, Y., CORTEZ, D., YAZDI, P., NEFF, N., ET.T.F.DGE, S. J. and QIN, J., 2000, BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes and Development, 14, 927–939.
   Google Scholar
• WEICHSELBAUM, R. R., NovE, J. and LiTrLE, J. B., 1978, Deficient recovery from potentially lethal radiation damage in ataxia telangiectasia and xeroderma pigmentosum. Nature, 271, 261–262.
   PubMed Web of Science ®Google Scholar
• WU, X., RANGANATHAN, V., WEISMAN, D. S., HEINE, W. F., CiccoNE, D. N., O'NEILL, T. B., CRICK, K. E., PIERCE, K. A., LANE, W. S., RATHBUN, G., LIVINGSTON, D. M. and WEAVER, D. T., 2000, ATM phosphorylation of Nijmegen Breakage Syndrome protein is required in a DNA damage response [see comments]. Nature, 405, 477–482.
   Google Scholar
• XU, X., WEAVER, Z., LINKE, S. P., Li, C., GOTAY, J., WANG, X.-W., HARIUS., C. C., RIED, T. and DG, C.-X., 1999, Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Molecular Cell, 3, 389–395.
   Google Scholar
• ZHANG, H., SONASUNDARAM, K., PENG, Y., TIAN, H., Bi, D., WEBER, B. L. and EL-DEWY, W. S., 1998, BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene, 16, 1713–1721.
   Google Scholar
• ZHAO, S., WENG, Y. C., YUAN, S. S., LIN, Y. T., Hsu, H. C., LIN, S. C., GERBINO, E., SONG, M. H., ZDZIENICKA, M. Z., GATTI, R. A., SHAY, J. W., ZW, Y., SHILOH, Y. and LEE, E. Y., 2000, Functional link between ataxia-telangiectasia and Nijmegen Breakage Syndrome gene products [see comments]. Nature, 405, 473–477.
   PubMed Web of Science ®Google Scholar
• ZHONG, Q, CHEN, C.-F., CH, P.-L. and LEE, W.-H., 2002, BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks. Journal of Biological Chemistry, 277, 28641–28647.
   Google Scholar
• Zuou, B. B. and ELLEDGE, S. J., 2000, The DNA damage response: putting checkpoints in perspective. Nature, 408, 433–439.
   PubMedGoogle Scholar